Skip to main content

and
  1. No Access

    Article

    Retinopathie erfordert Teamarbeit

    Diabetespatienten bemerken Sehminderungen meist erst bei fortgeschrittenen Netzhautdefekten. Dann kann allenfalls noch eine mäßige Sehverbesserung erzielt werden. Daher ist ein regelmäßiges Screening wichtig. ...

    Prof. Dr. med. Bernd Bertram, K. -D. Lemmen, H. Agostini, F. Ziemssen in Info Diabetologie (2018)

  2. No Access

    Article

    Die Barometer-Studie

    H.-P. Hammes, J. Egerer, F. Ziemssen, D. Drossel in Der Diabetologe (2017)

  3. No Access

    Article

    Netzhautkomplikationen bei Diabetes

    In der neuen Version der nationalen Versorgungsleitlinie (NVL) „Prävention und Therapie von Netzhautkomplikationen bei Diabetes“ (9/2015) sind die aktuellen Empfehlungen zu deren Diagnostik und Therapie zusamm...

    Prof. Dr. B. Bertram, K.-D. Lemmen, H. Agostini, F. Ziemssen in Der Diabetologe (2016)

  4. No Access

    Article

    Nationale Versorgungsleitlinie (NVL) Diabetische Retinopathie

    Die aktualisierte Nationale Versorgungsleitlinie (NVL) beinhaltet die konsentierten Empfehlungen zur Prävention und Behandlung von Netzhautkomplikationen bei Diabetes. Daten zur Epidemiologie zeigen eine Präva...

    Prof. Dr. F. Ziemssen, K. Lemmen, B. Bertram, H. P. Hammes in Der Ophthalmologe (2016)

  5. No Access

    Article

    Kommentar zu den neuen Leitlinien 2013 der Europäischen Gesellschaft für Kardiologie zu Diabetes, Prädiabetes und kardiovaskulären Erkrankungen

    Prof. Dr. N. Marx, S.D. Anker, H.-P. Hammes, C. Tschöpe in Der Kardiologe (2014)

  6. No Access

    Article

    Chronic hyperglycemia inhibits vasoregression in a transgenic model of retinal degeneration

    Vasoregression characterizes diabetic retinopathy in animal models and in humans. We have recently demonstrated that vasoregression is earlier initiated in a rat model of ciliopathy-induced retinal neurodegene...

    Y. Feng, Y. Wang, Z. Yang, L. Wu, S. Hoffmann, T. Wieland, N. Gretz in Acta Diabetologica (2014)

  7. Article

    Diabetic retinopathy in type 1 diabetes—a contemporary analysis of 8,784 patients

    The aim of this study was to analyse the risk profile for diabetic retinopathy under real-life conditions in a large cohort of patients with type 1 diabetes.

    H. P. Hammes, W. Kerner, S. Hofer, O. Kordonouri, K. Raile, R. W. Holl in Diabetologia (2011)

  8. Article

    Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina

    Diabetic retinopathy is the result of increased oxidative and nitrosative stress induced by chronic hyperglycaemia, and affects the vasculature and the neuroglia. Erythropoietin is a neuroprotective and an end...

    Q. Wang, F. Pfister, A. Dorn-Beineke, F. vom Hagen, J. Lin, Y. Feng in Diabetologia (2010)

  9. Article

    Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy

    Hyperglycaemia-induced mitochondrial overproduction of reactive oxygen species (ROS) is central to the pathogenesis of endothelial damage in diabetes. R-(+)-α-lipoic acid has advantages over classic antioxidan...

    J. Lin, A. Bierhaus, P. Bugert, N. Dietrich, Y. Feng, F. vom Hagen in Diabetologia (2006)

  10. Article

    Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides

    Vitronectin-receptor-type integrins (αv β 3 and αv β 5) are thought to be involved in the selective ablation of tumorigenic and other pathol...

    E. Chavakis, B. Riecke, J. Lin, T. Linn, R. G. Bretzel, K. T. Preissner in Diabetologia (2002)

  11. No Access

    Chapter

    Glukose

    Die Regulation des Energiestoffwechsels ist ein komplexes Wechselspiel zwischen Hormonen, exogenen Nährstoffen und dem Austausch von Substraten mit dem Ziel, eine konstante und ausreichende Versorgung aller Or...

    M. Brado, A. Bierhaus, A. Clemens, K. Dugi in Klinische Endokrinologie und Stoffwechsel (2001)

  12. Article

    Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation

    Aims/hypothesis. Proliferative diabetic retinopathy is a major debilitating disease causing most cases of blindness in humans in the Western world. Photocoagulation is the established therapy of ...

    J. Spranger, H.-P. Hammes, K. T. Preissner, H. Schatz, A. F. H. Pfeiffer in Diabetologia (2000)

  13. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)

  14. Article

    Differential accumulation of advanced glycation end products in the course of diabetic retinopathy

    Aims/hypothesis. Glycated proteins, formed by reaction of glucose and protein, react further yielding numerous, mostly undefined advanced glycation end products (AGE). The recently characterized ...

    H.-P. Hammes, A. Alt, T. Niwa, J. T. Clausen, R. G. Bretzel, M. Brownlee in Diabetologia (1999)

  15. Article

    Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Ne-(carboxymethyl) lysine independently of glycohaemoglobin concentrations

    Aims/hypothesis. We investigated whether either the amount of diabetes-induced intracellular oxidative stress or the concentration of hyperglycaemia-induced advanced glycation endproducts is asso...

    H.-P. Hammes, M. Brownlee, J. Lin, E. Schleicher, R. G. Bretzel in Diabetologia (1999)

  16. No Access

    Chapter

    Diabetische Retinopathie

    Eine 22jährige Patientin mit einem seit 15 Jahren bestehenden Typ-1-Diabetes stellt sich im Rahmen einer Kontrolluntersuchung in der Diabetesambulanz vor. Seit 3 Jahren ist keine Funduskontrolle in Mydriasis d...

    H.-P. Hammes in Kompendium Diabetologie (1999)

  17. Article

    The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster

    To assess the relationship between glucose and advanced glycation end products (AGE) and the relationship between AGE and retinal changes in vivo, we studied the time course of retinopathy over 12 months in t...

    H.-P. Hammes, B. Wellensiek, I. Klöting, E. Sickel, R. G. Bretzel in Diabetologia (1998)

  18. Article

    Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine

    In order to study the contribution of oxidant stress to the pathogenesis of experimental diabetic retinopathy, male streptozotocin diabetic Lewis rats were treated with the antioxidant and lipid-lowering comp...

    H. P. Hammes, A. Bartmann, L. Engel, P. Wülfroth in Diabetologia (1997)